Volitionrx (VNRX) Other financing activities (2019 - 2025)

Volitionrx (VNRX) posted Other financing activities of $28577.0 for Q4 2025, up 29060.2% on a QoQ basis from $98.0 in Q3 2020.

Volitionrx (VNRX) Other financing activities (2019 - 2025) Analysis & Trends

Volitionrx's Other financing activities history runs 3 years deep, the most recent figure standing at $28577.0 for Q4 2025.

Quarterly Other financing activities changed N/A year-over-year to $28577.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $28675.0 (up 29160.2% YoY) and the FY2025 annual result came in at $5.8 million, changed N/A from the prior year.
Other financing activities was $28577.0 for Q4 2025 at Volitionrx, up from $98.0 in the prior quarter.
Across five years, Other financing activities topped out at $28577.0 in Q4 2025 and bottomed at $28577.0 in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	201.40 Bn	194.75 Bn	6.27 Bn
2	Stryker	122.29 Bn	119.41 Bn	3.81 Bn
3	Medtronic	105.01 Bn	96.40 Bn	6.41 Bn
4	Boston Scientific	64.81 Bn	63.59 Bn	3.61 Bn
5	Edwards Lifesciences	55.28 Bn	51.60 Bn	1.29 Bn
6	Dexcom	29.06 Bn	27.94 Bn	750.30 Mn
7	Koninklijke Philips	29.02 Bn	25.93 Bn	2.07 Bn
8	GE HealthCare Technologies	28.27 Bn	26.20 Bn	1.98 Bn
9	Smith & Nephew	25.80 Bn	25.22 Bn	-
10	Volitionrx	109,643.10	-2.35 Mn	-

Download Data